Cas:29334-67-6 3-chloro-6-(3,5-dimethylpyrazol-1-yl)pyridazine manufacturer & supplier

We serve Chemical Name:3-chloro-6-(3,5-dimethylpyrazol-1-yl)pyridazine CAS:29334-67-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-chloro-6-(3,5-dimethylpyrazol-1-yl)pyridazine

Chemical Name:3-chloro-6-(3,5-dimethylpyrazol-1-yl)pyridazine
CAS.NO:29334-67-6
Synonyms:6-(3,5-dimethylpyrazol-1-yl)-3-chloropyridazine;3-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridazine;3-chloro-6-(3,5-dimethyl-pyrazol-1-yl)-pyridazine;3-chloro-6-(3,5-dimethylpyrazolyl)pyridazine;3-(3,5-dimethylpyrazol-1-yl)-6-chloro-pyridazine
Molecular Formula:C9H9ClN4
Molecular Weight:208.64800
HS Code:2933990090

Physical and Chemical Properties:
Melting point:112-114ºC
Boiling point:380.2ºC at 760mmHg
Density:1.36g/cm3
Index of Refraction:1.657
PSA:43.60000
Exact Mass:208.05200
LogP:1.93250

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 6-(3,5-dimethylpyrazol-1-yl)-3-chloropyridazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(3,5-dimethylpyrazol-1-yl)-6-chloro-pyridazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-(3,5-dimethylpyrazol-1-yl)-3-chloropyridazine Use and application,3-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridazine technical grade,usp/ep/jp grade.


Related News: Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients. 3-chloro-6-(3,5-dimethylpyrazol-1-yl)pyridazine manufacturer In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. 3-chloro-6-(3,5-dimethylpyrazol-1-yl)pyridazine supplier In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. 3-chloro-6-(3,5-dimethylpyrazol-1-yl)pyridazine vendor The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 3-chloro-6-(3,5-dimethylpyrazol-1-yl)pyridazine factory From the perspective of product structure, the varieties of these enterprises are mainly concentrated in vitamins, antipyretics and analgesics, antibiotics and corticosteroids (ie bulk drug substances).